CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities
Net earnings	$ 1,538	$ 1,613
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	214	210
Amortization of intangible assets	354	308
Asset impairments	90	19
Share-based compensation	133	133
Sale of inventory stepped-up to fair value at acquisition	99	9
Deferred income tax (benefit) expense	176	(31)
Changes in operating assets and liabilities:
Accounts receivable	257	103
Inventories	(226)	(230)
Accounts payable	(269)	(205)
Accrued expenses and other liabilities	(116)	(653)
Income taxes	(610)	(284)
Other, net	(279)	(155)
Net cash provided by operating activities	1,361	837
Investing activities
Acquisitions, net of cash acquired	(4,814)	(334)
Purchases of marketable securities	(27)	(32)
Proceeds from maturity of short-term investments	750	0
Proceeds from sales of marketable securities	32	31
Purchases of property, plant and equipment	(306)	(319)
Proceeds from settlement of net investment hedges	0	99
Proceeds from the sale of the Spinal Implants business	165	0
Other investing, net	(40)	30
Net cash used in investing activities	(4,240)	(525)
Financing activities
Proceeds (payments) on short-term borrowings, net	2	0
Proceeds from issuance of long-term debt	2,979	0
Payments on long-term debt	(650)	(600)
Payments of dividends	(641)	(609)
Cash paid for taxes from withheld shares	(115)	(127)
Other financing, net	(30)	(48)
Net cash provided by (used in) financing activities	1,545	(1,384)
Effect of exchange rate changes on cash and cash equivalents	57	(25)
Change in cash and cash equivalents	(1,277)	(1,097)
Cash and cash equivalents at beginning of period	3,652	2,971
Cash and cash equivalents at end of period	$ 2,375	$ 1,874